Back
Halozyme Therapeutics Stock Price Chart
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Buy
51
HALO
Halozyme Therapeutics
Last Price:
$46.95
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.62 | Sell |
| 20-day SMA: | 48.12 | Sell |
| 50-day SMA: | 51 | Sell |
| 200-day SMA: | 50.14 | Sell |
| 8-day EMA: | 47.61 | Sell |
| 20-day EMA: | 48.45 | Sell |
| 50-day EMA: | 50.73 | Sell |
| 200-day EMA: | 50.06 | Sell |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.11 | Sell |
| Relative Strength Index (14 RSI): | 40.79 | Sell |
| Chaikin Money Flow: | -4132103 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.97 - 48.99) | Sell |
| Bollinger Bands (100): | (49.23 - 60.41) | Sell |
Halozyme Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 46.93 while HALO 8-day simple moving average is 47.62, which is a Sell signal.
-
The stock price of HALO is 46.93 while Halozyme Therapeutics 20-day SMA is 48.12, which makes it a Sell.
-
Halozyme Therapeutics 50-day simple moving average is 51.00 while HALO share price is 46.93, making it a Sell technically.
-
HALO stock price is 46.93 and Halozyme Therapeutics 200-day simple moving average is 50.14, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
51
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a BuyThe current Halozyme Therapeutics [HALO] share price is $46.93. The Score for HALO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
6B
Price in USD:
46.93
Share Volume:
4.5M
Halozyme Therapeutics 52-Week Range
52-Week High:
65.53
52-Week Low:
33.15
Buy
51
Halozyme Therapeutics (HALO)
is a Buy
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?The Halozyme Therapeutics stock price is 46.93 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is not overvalued.
Is Halozyme Therapeutics Stock a Buy?
-
Halozyme Therapeutics share price is 46.93 while HALO 8-day exponential moving average is 47.61, which is a Sell signal.
-
The stock price of HALO is 46.93 while Halozyme Therapeutics 20-day EMA is 48.45, which makes it a Sell.
-
Halozyme Therapeutics 50-day exponential moving average is 50.73 while HALO share price is 46.93, making it a Sell technically.
-
HALO stock price is 46.93 and Halozyme Therapeutics 200-day simple moving average is 50.06, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is -1.11, suggesting Halozyme Therapeutics is a Sell
-
Halozyme Therapeutics Relative Strength Index (RSI) is 40.79, which suggest Halozyme Therapeutics is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics is (45.97 - 48.99), which suggest Halozyme Therapeutics is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics is (49.23 - 60.41), which suggest Halozyme Therapeutics is a Sell
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.